DK1135145T3 - Isoleret materiale med anti-organotrof virkning - Google Patents

Isoleret materiale med anti-organotrof virkning

Info

Publication number
DK1135145T3
DK1135145T3 DK99972922T DK99972922T DK1135145T3 DK 1135145 T3 DK1135145 T3 DK 1135145T3 DK 99972922 T DK99972922 T DK 99972922T DK 99972922 T DK99972922 T DK 99972922T DK 1135145 T3 DK1135145 T3 DK 1135145T3
Authority
DK
Denmark
Prior art keywords
organotrophic
effect
isolated material
mammalian
physico
Prior art date
Application number
DK99972922T
Other languages
Danish (da)
English (en)
Inventor
John Ernest Hart
Original Assignee
Endocrine Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Endocrine Pharmaceuticals Ltd filed Critical Endocrine Pharmaceuticals Ltd
Application granted granted Critical
Publication of DK1135145T3 publication Critical patent/DK1135145T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Liquid Crystal Substances (AREA)
  • Peptides Or Proteins (AREA)
DK99972922T 1998-12-01 1999-12-01 Isoleret materiale med anti-organotrof virkning DK1135145T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9826186.0A GB9826186D0 (en) 1998-12-01 1998-12-01 Chemical compound
PCT/GB1999/004013 WO2000032208A2 (fr) 1998-12-01 1999-12-01 Substance isolee a effet anti-organotrophique

Publications (1)

Publication Number Publication Date
DK1135145T3 true DK1135145T3 (da) 2003-06-23

Family

ID=10843297

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99972922T DK1135145T3 (da) 1998-12-01 1999-12-01 Isoleret materiale med anti-organotrof virkning

Country Status (14)

Country Link
US (2) US7572465B1 (fr)
EP (1) EP1135145B1 (fr)
JP (1) JP2002531410A (fr)
AT (1) ATE235910T1 (fr)
AU (1) AU758592B2 (fr)
CA (1) CA2353590A1 (fr)
DE (1) DE69906575T2 (fr)
DK (1) DK1135145T3 (fr)
ES (1) ES2192419T3 (fr)
GB (1) GB9826186D0 (fr)
NZ (1) NZ512123A (fr)
PT (1) PT1135145E (fr)
WO (1) WO2000032208A2 (fr)
ZA (1) ZA200104487B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0014029D0 (en) * 2000-06-08 2000-08-02 Endocrine Pharmaceuticals Limi Isolated material having size-inhibitory effects on cells,tissues and organs
US8367801B2 (en) 2008-01-10 2013-02-05 Endocrine Pharmaceuticals Limited Proteinaceous compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4734398A (en) * 1983-03-15 1988-03-29 University Of Southern California Follicular regulating protein

Also Published As

Publication number Publication date
NZ512123A (en) 2003-02-28
DE69906575D1 (de) 2003-05-08
CA2353590A1 (fr) 2000-06-08
DE69906575T2 (de) 2003-12-11
ATE235910T1 (de) 2003-04-15
WO2000032208A2 (fr) 2000-06-08
AU1399500A (en) 2000-06-19
JP2002531410A (ja) 2002-09-24
GB9826186D0 (en) 1999-01-20
ZA200104487B (en) 2002-07-25
ES2192419T3 (es) 2003-10-01
US7700132B2 (en) 2010-04-20
AU758592B2 (en) 2003-03-27
WO2000032208A3 (fr) 2000-10-19
EP1135145A2 (fr) 2001-09-26
PT1135145E (pt) 2003-07-31
US7572465B1 (en) 2009-08-11
EP1135145B1 (fr) 2003-04-02
US20050244507A1 (en) 2005-11-03

Similar Documents

Publication Publication Date Title
ATE214903T1 (de) Verwendung von perfluorkohlenwasserstoffen zur herstellung von potenzierungsmitteln für die ultraschallvermittelte hyperthermiebehandlung von biologischen geweben
NO844017L (no) Spormerkede konjugater av metallothionein og maalsoekende biologiske aktive molekyler
DK1196444T3 (da) Exendin-4-konjugater og deres medicinske anvendelighed
DE69521118D1 (de) Verbessertes verfahren zur fixierung von verkalkungsbestendigen biologischen geweben
ATE177421T1 (de) Wasserlösliches nimesulid-salz, sowie dessen verwendung zur behandlung von entzündungen
PT695758E (pt) Amidas e esteres de pentapeptidos inibidores de cancro humano
PT839154E (pt) Peptidos e composicoes biologicamente activos sua utilizacao
TR200000059T2 (tr) Piridin türevleri
CA2213533A1 (fr) Matrice extracellulaire resorbable pour la reconstruction du tissu cartilagineux
MX9606386A (es) Agentes que afectan la hemostasis trombotica.
ATE223486T1 (de) Bmp-9 zusammensetzungen
ATE294504T1 (de) Verfahren und zusammensetzungen zur behandlung von zellproliferationsstörungen
ATE466072T1 (de) Bandscheibe
DE60135019D1 (de) Elektroverarbeitetes kollagen
DE60001555D1 (de) Wässrige lösung zum konservieren von gewebe und organen
BR9609620A (pt) 2-aminocarbonil-1,2-bis(metilsulfonil)-1-(substituìda s)hidrazinas antitumorais.
HUP9901188A2 (hu) Új, meghatározott enzimkeverékek sejtkinyeréshez és sebkezeléshez
DK1135145T3 (da) Isoleret materiale med anti-organotrof virkning
ATE234862T1 (de) Glycoproteine mit lipidmobilisierenden eigenschaften und deren therapeutische verwendungen
EE200000163A (et) Protsess kirurgiliste instrumentide puhastamiseks
TR200200278T2 (tr) Kalsilitik bileşimler
MXPA02005069A (es) Agentes de enlace especificos para t3 y metodos para su uso.
DE60119285D1 (de) Verwendung von plgf zur vorbeugung oder behandlung von ischaemie oder schlaganfall
DE69726883D1 (de) Magnetotherapeutische vorrichtung
DE69922174D1 (de) Biomaterial zur behandlung von zahnfäule